Northpond Ventures GP, LLC - 22 Jun 2021 Form 4 Insider Report for Codex DNA, Inc. (TBIO)

Role: 10%+ Owner
Signature: Northpond Ventures GP, LLC, By: /s/ Patrick Smerkers, Senior Vice President, Finance and Operations
Issuer symbol: TBIO
Transactions as of: 22 Jun 2021
Net transactions value: +$7,500,000
Form type: 4
Filing time: 24 Jun 2021, 16:34:18 UTC
Previous filing: 17 Jun 2021
Next filing: 14 Sep 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TBIO	Common Stock	Conversion of derivative security		+9,375,380			9,375,380	22 Jun 2021	By: Northpond Ventures, LP	F1, F2
transaction	TBIO	Common Stock	Purchase	$7,500,000	+468,750	+5%	$16.00	9,844,130	22 Jun 2021	By: Northpond Ventures II, LP	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TBIO	Series A Preferred Stock	Conversion of derivative security		-5,214,851	-100%		0	22 Jun 2021	Common Stock	5,241,851		By: Northpond Ventures, LP	F1, F2
transaction	TBIO	Series A-1 Preferred Stock	Conversion of derivative security		-4,160,529	-100%		0	22 Jun 2021	Common Stock	4,160,529		By: Northpond Ventures, LP	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Upon the closing of the initial public offering of Codex DNA, Inc. (the "Issuer"), each share of Class A Preferred Stock, par value $0.0001 per share (the "Series A Preferred Stock"), of the Issuer and each share of Class A-1 Preferred stock, par value $0.0001 per share of the Issuer (the "Series A-1 Preferred Stock") automatically converted on a one-for-one basis into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"). The right to convert the Series A Preferred Stock and Series A-1 Preferred Stock into Common Stock had no expiration date.
F2	Northpond Ventures GP, LLC ("Northpond GP LLC") is the general partner of Northpond Ventures, LP ("Northpond Fund"), and Michael P. Rubin is the managing member of Northpond GP LLC. As a result, each of Northpond GP LLC and Mr. Rubin may be deemed to share beneficial ownership with respect to the shares held of record by Northpond Fund. Each of Northpond GP LLC and Mr. Rubin disclaim beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.
F3	Northpond Ventures GP II, LLC ("Northpond GP II LLC") is the general partner of Northpond Ventures II, LP ("Northpond Fund II"), and Michael P. Rubin is the managing member of Northpond GP II LLC. As a result, each of Northpond GP II LLC and Mr. Rubin may be deemed to share beneficial ownership with respect to the shares held of record by Northpond Fund II. Each of Northpond GP II LLC and Mr. Rubin disclaim beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.